Associations of serum 25-hydroxyvitamin D with hsCRP and other novel inflammatory biomarkers in children: a cross-sectional study

• Published in: BMJ open Vol. 14; no. 9; p. e083227
• Main Authors: Dong, Hongli, Wang, Feiying, Gao, Liang, Xu, Xiaojing, Ni, Yufei
• Format: Journal Article
• Language: English
• Published: England British Medical Journal Publishing Group 05.09.2024; BMJ Publishing Group LTD; BMJ Publishing Group
• Subjects: Age; Biomarkers; Biomarkers - blood; Blood; Blood platelets; Breastfeeding & lactation; C-Reactive Protein - analysis; C-Reactive Protein - metabolism; Child; Child, Preschool; China; Chronic illnesses; Congenital diseases; Cross-Sectional Studies; Diabetes; Erythrocyte Indices; Female; Hospitals; Humans; Infant; Inflammation; Inflammation - blood; Leukocyte Count; Leukocytes; Lymphocytes; Male; Mean Platelet Volume; Neutrophils; Neutrophils - metabolism; Nutrition and Metabolism; nutritional support; Original Research; paediatric endocrinology; Pediatrics; Platelet Count; Regression analysis; Vitamin D; Vitamin D - analogs & derivatives; Vitamin D - blood; China; paediatric endocrinology; cross-sectional studies; nutritional support
• ISSN: 2044-6055; 2044-6055
• DOI: 10.1136/bmjopen-2023-083227

ObjectivePrevious studies have shown the anti-inflammatory effect of 25-hydroxyvitamin D (25(OH)D) and the crucial roles of high-sensitive C reactive protein (hsCRP) and novel inflammatory markers (red blood cell distribution width–platelet count ratio (RDWPCR), mean platelet volume–platelet count ratio (MPVPCR), neutrophil–lymphocyte ratio (NLR) and white blood cell–neutrophil ratios (WBCNR)) in several diseases, but scarce data explored the associations of 25(OH)D with hsCRP and novel inflammatory markers. This study aimed to investigate these associations in children.DesignCross-sectional study.SettingChildren in China.Participants10141 children (mean age 14.6 months) were included.Primary and secondary outcome measuresHsCRP, red blood cell distribution width, platelet count, mean platelet volume, neutrophil, lymphocyte and white blood cell were measured.ResultsOverall, serum 25(OH)D was inversely associated with hsCRP and novel inflammatory biomarkers. In multivariable analysis, serum 25(OH)D was inversely associated with hsCRP and novel inflammatory biomarkers (Q quartile (Q) 4 vs Q1: 1129.75 vs 2090.99 for hsCRP; 4246.94 vs 6829.89 for RDWPCR; 4863.57 vs 5545.66 for MPVPCR; 4345.76 vs 6507.46 for NLR; 2418.84 vs 2868.39 for WBCNR). Similar results also were observed in stratified analyses by sex (boys and girls). Moreover, serum 25(OH)D was inversely associated with elevated inflammation levels. After adjustment for other potential covariates, inverse associations between serum 25(OH)D and elevated inflammation levels were still observed. The corresponding ORs (95% CI) were 0.05 (0.04, 0.06) for hsCRP, 0.13 (0.11, 0.15) for RDWPCR, 0.74 (0.64, 0.85) for MPVPCR, 0.11 (0.09, 0.13) for NLR and 0.57 (0.49, 0.66) for WBCNR in the fourth quartile compared with the first quartile, respectively.ConclusionsGenerally, the graded and inverse associations of serum 25(OH)D with hsCRP and four novel inflammatory markers (RDWPCR, MPVPCR, NLR and WBCNR) were observed. The present study provided further support for the anti-inflammatory effects of 25(OH)D.